Jiang X, Clark RA, Liu L et al.Skin infection generates non-migratory memory CD8+T RM cells providing global skin immunity. Nature 483:227-231

Department of Dermatology and Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature (Impact Factor: 41.46). 03/2012; 483(7388):227-31. DOI: 10.1038/nature10851
Source: PubMed


Protective T-cell memory has long been thought to reside in blood and lymph nodes, but recently the concept of immune memory in peripheral tissues mediated by resident memory T (T(RM)) cells has been proposed. Here we show in mice that localized vaccinia virus (VACV) skin infection generates long-lived non-recirculating CD8(+) skin T(RM) cells that reside within the entire skin. These skin T(RM) cells are potent effector cells, and are superior to circulating central memory T (T(CM)) cells at providing rapid long-term protection against cutaneous re-infection. We find that CD8(+) T cells are rapidly recruited to skin after acute VACV infection. CD8(+) T-cell recruitment to skin is independent of CD4(+) T cells and interferon-γ, but requires the expression of E- and P-selectin ligands by CD8(+) T cells. Using parabiotic mice, we further show that circulating CD8(+) T(CM) and CD8(+) skin T(RM) cells are both generated after skin infection; however, CD8(+) T(CM) cells recirculate between blood and lymph nodes whereas T(RM) cells remain in the skin. Cutaneous CD8(+) T(RM) cells produce effector cytokines and persist for at least 6 months after infection. Mice with CD8(+) skin T(RM) cells rapidly cleared a subsequent re-infection with VACV whereas mice with circulating T(CM) but no skin T(RM) cells showed greatly impaired viral clearance, indicating that T(RM) cells provide superior protection. Finally, we show that T(RM) cells generated as a result of localized VACV skin infection reside not only in the site of infection, but also populate the entire skin surface and remain present for many months. Repeated re-infections lead to progressive accumulation of highly protective T(RM) cells in non-involved skin. These findings have important implications for our understanding of protective immune memory at epithelial interfaces with the environment, and suggest novel strategies for vaccines that protect against tissue tropic organisms.

Full-text preview

Available from:
  • Source
    • "We found that the overall frequency of IL-2þ A11R 198–205 -specific CD8 T cells was slightly lower in the protected animals (average 1.0%) than in the unprotected ones (average 1.6%), but this likely just means that the presence of higher levels of antigen was continuing to stimulate the T cells, rather than reflecting on any intrinsic T cell deficiency. Resident effector memory T cells have been reported to be important for protection against VACV in parabiotic studies (Jiang et al., 2012), and the enhanced effector function of LCMV-immune T cells resembles that of effector memory cells. This would potentially make cross-reactive LCMV-specific memory T cells better at mediating heterologous immunity as compared to the cross-reactive VACV-specific T cells with a more resting central memory cell phenotype. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Heterologous immunity refers to the phenomenon whereby a history of an immune response against one pathogen can provide a level of immunity to a second unrelated pathogen. Previous investigations have shown that heterologous immunity is not necessarily reciprocal, such as in the case of vaccinia virus (VACV). Replication of VACV is reduced in mice immune to a variety of pathogens, while VACV fails to induce immunity to several of the same pathogens, including lymphocytic choriomeningitis virus (LCMV). Here we examine the lack of reciprocity of heterologous immunity between VACV and LCMV and find that they induce qualitatively different memory CD8 T cells. However, depending on the repertoire of an individual host, VACV can provide protection against LCMV simply by experimentally amplifying the quantity of T cells cross-reactive with the two viruses. Thus, one cause for lack of reciprocity is differences in the frequencies of cross-reactive T cells in immune hosts. Copyright © 2015 Elsevier Inc. All rights reserved.
    Virology 03/2015; 482:89-97. DOI:10.1016/j.virol.2015.03.002 · 3.32 Impact Factor
  • Source
    • "Contrast this with the situation in humans (described above), in which DTH is a measurement of long-term T cell memory that was previously generated in response to (presumed) natural exposure to an infectious pathogen, typically via the respiratory system. Upon skin inoculation with antigen, memory T cells are either resident in the tissue to respond to the challenge (likely for VZV), or are recruited to the site of challenge from the circulation (likely for MTb) (Gebhardt et al. 2009; Jiang et al. 2012 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Translational research programs offer incredible opportunities to bring cutting edge science into clinical practice. To facilitate these medical advances, funding agencies are increasingly focusing on a translational "payoff" within grant applications and larger programs. As this is the underlying promise of biomedical research-delivering advances to public health to improve the quality of life-such strategic initiatives are paramount. However, the process of taking experimental observations between model systems and human subjects can be extraordinarily frustrating. We brought together the collective expertise of our mouse and human immunology research programs to reverse engineer a clinical observation into a mouse model system. Our goal was to model (in mice) the age-related impaired delayed-type hypersensitivity response observed in humans, and then evaluate the efficacy of interventions to improve cutaneous immunity. We report here on what worked, what didn't, and what we learned along the way.
    Biogerontology 07/2014; 16(2). DOI:10.1007/s10522-014-9517-0 · 3.29 Impact Factor
  • Source
    • "These experiments suggest that TRM induced by infection or vaccination should persist for very long periods in the immediate environment where they were formed and provide robust site-specific immunity. While such site-specific immunity may be of little use against subsequent infections at remote sites, repeated infections can induce TRM in non-involved regions of skin (28), potentially providing more widespread protection at least in this tissue. Whether this is the case with many infections or tissues and the protective efficacy of these more dispersed TRM needs to be investigated further. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The skin is a large and complex organ that acts as a critical barrier protecting the body from pathogens in the environment. Numerous heterogeneous populations of immune cells are found within skin, including some that remain resident and others that can enter and exit the skin as part of their migration program. Pathogen-specific CD8(+) T cells that persist in the epidermis following infection are a unique population of memory cells with important roles in immune surveillance and protective responses to reinfection. How these tissue-resident memory T cells form in the skin, the signals controlling their persistence and behavior, and the mechanisms by which they mediate local recall responses are just beginning to be elucidated. Here, we discuss recent progress in understanding the roles of these skin-resident T cells and also highlight some of the key unanswered questions that need addressing.
    Frontiers in Immunology 07/2014; 5:332. DOI:10.3389/fimmu.2014.00332
Show more